A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance
The journal of antimicrobial chemotherapy/Journal of antimicrobial chemotherapy